The Association of the British Pharmaceutical Industry (ABPI) has launched an online campaign to showcase the value the sector brings to the UK.
Its release comes a few months before negotiations to leave the European Union are expected to begin and pharma is among the industries keen to maintain its position in the post-Brexit environment.
Ahead of that the ABPI has released a new film and online resource aimed at providing a comprehensive overview of the UK pharmaceutical industry and the value of its work.
The trade association's short film - titled 'Only Just Begun' - celebrates the UK's history of innovative medical research and development and looks to the next generation of scientists to take up this mantle.
'Only Just Begun' shows original and archive footage from AstraZeneca, GlaxoSmithKline, Novo Nordisk and Pfizer, as researchers and healthcare professionals work to bring better treatments and care to patients across the country.
The ABPI has also launched an accompanying online resource that aims to demonstrate how its 60 members have contributed to improving patient health and survival, growing patient engagement in the development of medicines, and enabling innovation in UK-based research.
According to the association, 81% of all branded medicines used by the NHS are supplied by its member organisations, but the resource also emphasises that there is still room for improvement.
It states that people living in the UK are 'significantly less likely to have access' to new medicines for the first five years after launch, with the UK's use of new treatments currently at 11% of similar markets' average.
Aileen Thompson, executive director of communications at the ABPI, said: “Medicines and vaccines help us live longer, better lives and offer one of the greatest hopes we have for the future of human health.
“These new resources tell the story of what we do and why, and we hope they will inspire others to find out more about the life-changing discoveries, vaccines and medicines which our members deliver.”